We have amazing support!
Meet our International Ambassadors.
Kenneth Lyons Jones
Dr. Kenneth Lyons Jones is a world-renowned pediatrician, dysmorphologist, teratologist and researcher in the field of birth defects. He is a Distinguished Professor and Chief of the Division of Dysmorphology and Teratology in the Department of Pediatrics, School of Medicine at the University of California San Diego. Dr. Jones is actively involved in research, clinical services, training and education, and policy focused on the clinical delineation, diagnosis and prevention of adverse pregnancy outcomes and birth defects resulting from environmental exposures. He is also founder and medical director of MotherToBaby California, a teratogen information service that provides women and clinicians individualized assessments regarding the safety of exposures in pregnancy and lactation.
Since first describing Fetal Alcohol Syndrome in 1973 with David W. Smith, M.D., Dr. Jones has made extensive contributions to the prevention, improved diagnosis, and treatment of fetal alcohol spectrum disorders (FASD) through his research efforts and clinical care. He has trained physicians from all over the world in the diagnosis of FASDs and has organized FASD evaluation programs worldwide. Currently, he is head of the Dysmorphology Research Resource, which is part of the larger National Institute on Alcohol Abuse and Alcoholism consortium studying this disorder.
Dr. Jones has authored over 250 publications in scientific journals and is the author of Smith’s Recognizable Patterns of Human Malformation, now in its 7th edition. Dr. Jones is a former president of the Western Society for Pediatric Research, the Teratology Society, and the Organization of Teratology Information Specialists and is currently a member of the Association of American Physicians. Research Professor, School of Global Public Health, University of North Carolina
Dr Christina Chambers
Director of Clinical Research
Professor Albert Chudley
MD, FRCPC, FCCMG, Professor Emeritus
He has taught and supervised students at the undergraduate, graduate and postgraduate levels on the topics of genetics, Fetal Alcohol Spectrum Disorders, neonatology, paediatrics and ethics. He led in the development of the core curriculum for all postgraduate residents at the University of Manitoba. He has served as a member of the FAS advisory committee to Health Canada and subsequently the Public Health Agency Canada where he co-led the development of the 2005 FASD Diagnostic Guidelines and co-authored the 2016 Guidelines update. Professor Chudley has been a consultant to national and international bodies related to FASD diagnosis and management. He was co-lead in the FASD arm of the Centre of Excellence funded NeuroDevNet research program (now Kids Brain Health). He has served the community as a leader or member of several local and national boards.
Professor Chudley has earned numerous awards and distinctions, including the service recognition award from St. Amant, the Medical Staff Person of the Year Award from the Health Sciences Centre, Winnipeg and the Manitoba Service Excellence Award. He was the recipient of the André Boivin Award for his work in Maternal/Fetal Toxicology. In 2008 he was the recipient of the Founders Award from the Canadian College of Medical Geneticists, an award in recognition of “outstanding achievement and exceptional commitment to Medical Genetics” by his peers. He lives with his wife in semi-retirement in Winnipeg. He has 5 children and 13 grandchildren, so his life remains busy and fulfilling.
Professor Philip May
Professor Philip A. May is an American Demographer/Epidemiologist who has studied fetal alcohol spectrum disorders (FASD) and overseen the implementation and evaluation of FASD prevention and intervention programs in the United States, South Africa, and Italy since 1980.
He currently serves as a Professor in the Gillings School of Global Public Health of the University of North Carolina at Chapel Hill (USA) working from the UNC Nutrition Research Institute. He also holds other academic titles. He is a Professor Emeritus from the University of New Mexico, Albuquerque, New Mexico (USA); Extraordinary Professor, Stellenbosch University, Faculty of Medicine and Health Sciences, Cape Town, Western Cape Province (South Africa); and Adjunct Professor of Pediatrics, Sanford School of Medicine of the University of South Dakota, Sioux Falls, South Dakota (USA).
Professor May began his professional career in public health as a Commissioned Officer in the United States Public Health Service working for the U.S. National Institute of Mental Health and the U.S. Indian Health Service in several States across America. His decades-long commitment to FASD research and prevention stems from both personal and professional experience with children with FASD and their mothers. In 1980 he directed and carried out the first population-based epidemiology study of fetal alcohol syndrome in the United States, working with and among Native American Tribes in the rural Southwestern United States. After the results of that first study were published in 1983, he and his multidisciplinary team of dedicated and talented professionals have carried out many other studies of the prevalence and characteristics of children with FASD and maternal risk factors. Nine such studies have been completed in the Western Cape Province of South Africa, two in the Lazio Region of Italy, and twelve studies in three different regions of the United States. Prof. May directed the National Indian Fetal Alcohol Syndrome Prevention Program from 1983 – 87, and has been the principal investigator of several recent community-wide FASD prevention efforts in the USA and South Africa.
“The public health importance of preventing prenatal alcohol use throughout the world cannot be underestimated. My hope, and that of all of the dedicated professionals with whom I work, is that every single child in the world will be born unexposed to alcohol in the prenatal period.”
Professor Jeffrey Wozniak
Dr. Wozniak is a clinical paediatric neuropsychologist at the University of Minnesota whose research is focused on Fetal Alcohol Spectrum Disorders. He directs the University’s FASD Research Program which conducts neuroimaging, neurocognitive, and intervention studies in FASD. He is the past-president of the Fetal Alcohol Spectrum Disorders Study Group (FASDSG). Dr. Wozniak’s research group is also part of the Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD). His recent efforts have included a randomized controlled trial of choline supplementation in children with FASD – the goal of which is to develop a treatment for the neurodevelopmental aspects of the disorder. Dr. Wozniak and his team work closely with their colleagues in the Minnesota Organization on Fetal Alcohol Syndrome (MOFAS) to inform the local community about the dangers of prenatal alcohol exposure and to train physicians and other professionals in diagnosing and assisting affected individuals.
Dr Nancy Poole
Dr Nancy Poole is the Prevention Lead for the CanFASD Research Network guiding a pan-Canadian network of researchers, service providers, policy analysts and community-based advocates working on FASD prevention. Nancy is also the Director of the Centre of Excellence for Women’s Health (CEWH), a virtual, non-profit research centre known internationally for its leadership in gender and health. In her role as Director of CEWH, Nancy leads knowledge translation, network development, and research related to improving policy and service provision for girls and women facing a range of health and social concerns, including substance use problems. In the past decade Nancy has had over 125 academic papers, technical reports and book chapters published, and has co-authored 5 books on the topics of trauma-informed practice, gender-transformative responses to substance use, health promotion and transdisciplinarity. Nancy participates on Canadian and international research teams studying Indigenous approaches to FASD prevention and healing from substance use concerns, and strives to be a solid ally in research, practice and policy initiatives undertaken with Indigenous partners. Overall, Nancy is known as a catalyst for bringing knowledge to practice to make social change designed to improve the lives of girls and women with substance use concerns.
Dr Svetlana Popova
MD, PhDs, MPH
Dr. Svetlana Popova, MD, PhDs, MPH is a Senior Scientist at the Institute for Mental Health Policy Research, Centre for Addiction and Mental Health (CAMH) which is the Pan American Health Organization (PAHO) / World Health Organization (WHO) Collaborating Centre. She is also an Associate Professor at the Dalla Lana School of Public Health Epidemiology Division and at the Factor Inwentash Faculty of Social Work at the University of Toronto. She has an appointment as a Graduate Faculty Associate Member with the Institute of Medical Science, University of Toronto.
Dr. Popova’s research focuses on substance abuse and disease burden, and evidence-based policy development. She has a particular interest in the epidemiology, economic cost, prevention and intervention strategies related to Fetal Alcohol Spectrum Disorder (FASD).
Currently, Dr. Popova is leading one of the largest studies, guided by the WHO and the National Institute on Alcohol Abuse and Alcoholism (NIAAA), on determining the global prevalence of FASD among children in low- and middle-income countries of Eastern and Central Europe, Africa, and Canada (with more countries to join within the next five years). Dr. Popova was a principal investigator of the Canadian component of this study which is part of the National Strategic Projects Fund in Canada. She was also a principal investigator of the study on estimating the burden and economic cost associated with FASD in Canada, supported by the Public Health Agency of Canada.
Dr. Popova has been published in high-impact journals such as the Lancet, The Lancet Global Health, JAMA Pediatrics, International Journal of Epidemiology, American Journal of Epidemiology, and Addiction. Her research is widely read and cited.
Dr. Popova collaborates on the Global Burden of Disease studies (GBD) on alcohol consumption as a risk factor for burden of disease. She was also one of the conductors of the second Canadian Cost Study on Substance Abuse and Avoidable Cost of Alcohol Abuse in Canada.